Compound Detail
CHEMBL519248
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL519248 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | WDCNWURFEOCGAX-LBPRGKRZSA-N |
2
Targets
2
Activities
2
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
387.5
MW (Da)
1.49
ALogP
5
HBA
5
HBD
139.3
PSA (Ų)
0.53
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 5.5
IC50 1 meas. best 8.3
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Serine/threonine-protein kinase Chk1 CHEMBL4630 | IC50 | 8.3 | 8.3 | 5.0 | 1 |
| HT-29 CHEMBL384 | EC50 | 5.5 | 5.5 | 3200.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Serine/threonine-protein kinase Chk1 | IC50 | = | 5.0 | nM | 8.3 | Inhibition of Chk1 | 18547806 |
| HT-29 | EC50 | = | 3200.0 | nM | 5.5 | Abrogation of camptothecin induced cell cycle arrest at G2/M phase in human HT29... | 18547806 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 18547806 | 10.1016/j.bmcl.2008.05.016 | HT-29 | 1 |
| 18547806 | 10.1016/j.bmcl.2008.05.016 | Serine/threonine-protein kinase Chk1 | 1 |
| 18547806 | 10.1016/j.bmcl.2008.05.016 | Cyclin-dependent kinase 2-associated protein 1 | 1 |
Data from ChEMBL 36 via Core Engine